NDI (Neuro Device Innovations) is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies. NDI pursues, funds and develops opportunities that address unmet clinical needs with the potential to provide significant returns to its investors.
NDI is focused on the worldwide market for neurodevices, such as stimulators, leads, surgical equipment and software – a market exceeding $6 billion per year. Significant growth is projected over the next decade due to age-related and treatment–resistant neurological diseases and disorders, including sub-acute and chronic pain, Parkinson’s disease, depression, epilepsy, obesity, stroke and other disorders. Within the next decade, the neurodevice sector is expected to rival the $18 billion cardiac market, as new markets proliferate, especially in those areas where drug therapies are ineffective.
Founded in 2002, NDI is headquartered in Cleveland, Ohio with locations in North Carolina’s Research Triangle and Minneapolis, Minnesota. NDI has a proven track record of moving technologies from innovation to commercialization. In April 2008, NDI sold its first portfolio company to Medtronic Inc. for $42 million, returning over 150 times the original investment back to investors.
ABOUT NDI HEALTHCARE FUND
Since 2008, the NDI Healthcare Fund and its portfolio companies have raised $26 million, including $17 million in private equity and another $9 million in grants and loans from sources such as the National Institutes of Health, U.S. Department of Defense, and the State of Ohio’s Third Frontier Program. These funds are used to develop opportunities exclusively in neurotechnology that address unmet needs and have the potential to provide significant returns to investors.
ABOUT NDI MEDICAL, LLC
NDI Medical greatly reduces the investment of time and capital required to incubate and launch new products and therapies, taking ideas from innovation to exit in the most efficient manner possible by uniquely leveraging:
PROPRIETARY PLATFORM TECHNOLOGIES consisting of implantable pulse generators, external pulse generators, leads, surgical deployment tools, external programmers, and patient controllers that can be applied to many different therapeutic applications or adapted for new devices; and
A PIPELINE OF SIGNIFICANT COMMERCIALIZATION OPPORTUNITIES arising from NDI Medical’s research and development teams working closely with targeted clinician end-users and an extensive network in the medical device and investment community including collaborations with:
- The Ohio Neurostimulation and Neuromodulation Partnership: a collaboration of NDI, Case Western Reserve University, Cleveland Clinic, and MetroHealth Medical Center dedicated to the commercialization of technologies that address critical neurological disorders
- The Cleveland Functional Electrical Stimulation (FES) Center: one of the world’s leading research centers developing advanced neurotech technologies and integrating them into cutting-edge clinical care
- Duke University: NDI, with its Research and Development offices located in nearby Chapel Hill, leverages its proximity along with its strong relationship to the researchers and clinicians at Duke.
OUR HISTORY OF COMMITMENT TO OHIO:
In addition to the Ohio-based innovation pipeline partnerships above, NDI has a proud history of supporting Ohio companies and service organizations. Where possible we use local vendors, parts and services. Below are just a few of the Ohio-based companies we have current or past collaborations with:
Delta Systems, Inc
|LAD Technology, Inc
Morgan Technical Ceramics
The Technology House